Search Results for keywords:"research"

Found 4 results

Search Results: keywords:"research"

💰 Only
Oldest Newest
  • 2025-01767 — Importer of Controlled Substances Application: Vici Health Sciences, LLC
    Type:Notice
    Citation:90 FR 8303
    Reading Time:about a minute or two

    Vici Health Sciences, LLC has applied to become an importer of specific controlled substances to support their research and clinical trials. The Drug Enforcement Administration (DEA) is accepting public comments and objections to this application until February 27, 2025. Interested parties can submit their comments electronically through the Federal eRulemaking Portal. The DEA has specified that this permit will not authorize the import of finished medication forms for sale.

    Simple Explanation

    Vici Health Sciences wants permission to bring certain special medicines into the country for research, but you can't buy these as regular medicine. The government is listening to people's opinions on this until February 28, 2025.

  • 2021-03919 — Importer of Controlled Substances Application: Myonex Inc
    Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    Myonex Inc has applied for registration as an importer of specific controlled substances, according to a notice from the Drug Enforcement Administration (DEA). The substances are intended for use in clinical trials, research, and analytical purposes, and not for commercial sale of finished dosage forms. Interested parties have until March 29, 2021, to submit written comments or objections, or to request a hearing regarding this application. Written submissions should be directed to the DEA at their office in Springfield, Virginia.

    Simple Explanation

    Myonex Inc wants to bring in some special medicines from other countries to use in experiments and tests but not to sell them in stores. If anyone has questions or concerns, they can tell the people in charge by March 29, 2021.

  • 2025-06712 — Importer of Controlled Substances Application: Myonex LLC
    Type:Notice
    Citation:90 FR 16555
    Reading Time:about a minute or two

    Myonex LLC has submitted an application to the Drug Enforcement Administration (DEA) to become a registered importer of certain controlled substances. The company plans to import these substances in dosage forms specifically for use in clinical trials, research, and analytical work, but not for commercial sales. Interested parties, including manufacturers or other applicants, are invited to submit comments or objections to this application by May 19, 2025, and they also have the option to request a hearing. No commercial activities involving the finished dosage forms are allowed under this registration.

    Simple Explanation

    Myonex LLC wants permission to bring in certain special medicines from outside the country to use for tests and studies, but not to sell. People who might worry about this can say something about it by May 19, 2025.

  • 2025-02737 — Importer of Controlled Substances Application: Lonza Tampa, LLC
    Type:Notice
    Citation:90 FR 9735
    Reading Time:about a minute or two

    Lonza Tampa, LLC has applied to the Drug Enforcement Administration to become registered as an importer of controlled substances, specifically focusing on the drug code 7437 (Psilocybin). They plan to use Psilocybin as a bulk active pharmaceutical ingredient for clinical trials, research, and analytical purposes. The DEA is allowing registered bulk manufacturers or applicants to submit electronic comments or objections to this application by March 20, 2025. Requests for a hearing can also be submitted by this date.

    Simple Explanation

    Lonza Tampa, LLC wants permission from the government to bring in a special kind of drug called psilocybin for science experiments and tests, and people can tell the government what they think about this until March 20, 2025.